EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieÜbersichtsarbeit

Supplemental Breast Cancer Screening with Contrast-enhanced Mammography or Abbreviated MRI for Extremely Dense Breasts: The DENSE-2 Trial

Sophie E L van Grinsven iD, Evelyn M Monninkhof iD, Ritse M Mann iD, Marc B I Lobbes, Mireille J M Broeders iD, Nicolien T van Ravesteyn iD, Adriana M J Bluekens, Paul J van Diest, Monique D Dorrius iD, Katya M Duvivier iD, Maaike P M Gielens, Mathijn D F de Jong iD und 12 weitere

Radiology · 2026

DOI: 10.1148/radiol.260333 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Radiology, 2026. Verfasst von Sophie E L van Grinsven und 23 weiteren Autor:innen. Beteiligte Einrichtung: Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, th…. Hauptthemen laut MEDLINE: Breast Neoplasms, Contrast Media, Magnetic Resonance Imaging, Mammography. Die Arbeit nennt 35 Literaturangaben. Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Dense Tissue and Early Breast Neoplasm Screening-2 (DENSE-2) trial addresses whether supplemental contrast-enhanced mammography and abbreviated MRI can lead to fewer interval cancers in women with extremely dense breasts compared with mammography.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsContrast MediaMagnetic Resonance ImagingMammographyEarly Detection of CancerBreast DensityFemaleHumansNetherlandsSensitivity and SpecificityMiddle Aged

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, 3584 CG, Utrecht, the Netherlands.
  • Department of Radiology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
  • Department of Radiology, the Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Department of Medical Imaging, Zuyderland Medical Centre, Sittard-Geleen, the Netherlands.
  • Dutch Expert Centre for Screening (LRCB), Nijmegen, the Netherlands.
  • IQ Health Science Department, Radboud University Medical Center, Nijmegen, the Netherlands.

ORCID-Profile: Sophie E L van Grinsven, Evelyn M Monninkhof, Ritse M Mann, Mireille J M Broeders, Nicolien T van Ravesteyn, Monique D Dorrius, Katya M Duvivier, Mathijn D F de Jong, Marc C J M Kock, Carla Meeuwis, Thiemo J A van Nijnatten, Johanna P Trap-de Jong, Jeroen Veltman, Wouter B Veldhuis, Carla H van Gils

Förderung

  • ZonMw

Zitieren

APA

van Grinsven, S. E. L., Monninkhof, E. M., Mann, R. M., Lobbes, M. B. I., Broeders, M. J. M., van Ravesteyn, N. T., Bluekens, A. M. J., van Diest, P. J., Dorrius, M. D., Duvivier, K. M., Gielens, M. P. M., de Jong, M. D. F., Kock, M. C. J. M., Loo, C. E., Meeuwis, C., de Monyé, C., van Nijnatten, T. J. A., Pijnappel, R. M., Trap-de Jong, J. P., …, & DENSE-2 trial study group (2026). Supplemental Breast Cancer Screening with Contrast-enhanced Mammography or Abbreviated MRI for Extremely Dense Breasts: The DENSE-2 Trial. Radiology. https://doi.org/10.1148/radiol.260333

Vancouver

van Grinsven SEL, Monninkhof EM, Mann RM, Lobbes MBI, Broeders MJM, van Ravesteyn NT, et al. Supplemental Breast Cancer Screening with Contrast-enhanced Mammography or Abbreviated MRI for Extremely Dense Breasts: The DENSE-2 Trial. Radiology. 2026. doi:10.1148/radiol.260333

BibTeX
@article{vanGrinsven2026,
  author = {van Grinsven, Sophie E L and Monninkhof, Evelyn M and Mann, Ritse M and Lobbes, Marc B I and Broeders, Mireille J M and van Ravesteyn, Nicolien T and Bluekens, Adriana M J and van Diest, Paul J and Dorrius, Monique D and Duvivier, Katya M and Gielens, Maaike P M and de Jong, Mathijn D F and Kock, Marc C J M and Loo, Claudette E and Meeuwis, Carla and de Monyé, Cécile and van Nijnatten, Thiemo J A and Pijnappel, Ruud M and Trap-de Jong, Johanna P and Veltman, Jeroen and Veldhuis, Wouter B and van Gils, Carla H and DENSE-2 Trial Study Group, DENSE-2 Trial Study Group and DENSE-2 trial study group, DENSE-2 trial study group},
  title = {Supplemental Breast Cancer Screening with Contrast-enhanced Mammography or Abbreviated MRI for Extremely Dense Breasts: The DENSE-2 Trial},
  journal = {Radiology},
  year = {2026},
  doi = {10.1148/radiol.260333}
}
Kostenlos starten →